Christina Twyman-Saint Victor

Executive Medical Director, Early Development Oncology @Amgen

Princeton, NJ, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2025 — Present

Executive Medical Director, Early Development Oncology @Amgen

View department →

EDUCATION

2002 — 2007

The Johns Hopkins University School of Medicine

Doctor of Medicine (M.D.)

2013 — 2016

University of Pennsylvania

Master of Science in Translational Research

1998 — 2002

Duke University

Bachelor’s Degree

ABOUT CHRISTINA TWYMAN-SAINT VICTOR

I am a physician-scientist with extensive experience in oncology drug development, bridging the gap between cutting-edge research and clinical application. My expertise lies in shaping early-stage drug development strategies, designing innovative clinical trials, and leading cross-functional teams to bring novel therapies from concept to reality.With a strong foundation in both clinical practice and research, I have provided patient care in gastroenterology while investigating novel treatment approaches to improve outcomes in oncology. My research has focused on resistance mechanisms to immunotherapy, biomarker-driven strategies, and translating scientific discoveries into impactful clinical advancements. By integrating clinical insights with oncology drug development, I aim to accelerate the development of innovative therapies that address unmet medical needs.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Christina Twyman-Saint Victor — Executive Medical Director, Early Development Oncology at Amgen in Princeton, NJ, US | Unifers